ENANTA PHARMACEUTICALS, INC Lessee, Operating Lease, Liability, Undiscounted Excess Amount
ENANTA PHARMACEUTICALS, INC (ENTA) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $27.79 million as of 2025-09-30, per its 10-K filed 2025-11-19.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2025-11-19
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $27.79M.
- 2025-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $29.07M.
- 2025-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $30.37M.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $31.68M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-09-30 | $27.79M 10-K · filed 2025-11-19 |
| 2025-06-30 | $29.07M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $30.37M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $31.68M 10-Q · filed 2025-02-12 |
| 2024-09-30 | $33.00M 10-K · filed 2024-11-27 |
| 2024-06-30 | $33.79M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $34.76M 10-Q · filed 2024-05-08 |
| 2023-09-30 | $8.02M 10-K · filed 2023-11-22 |
| 2022-09-30 | $9.79M 10-K · filed 2022-11-23 |
| 2021-09-30 | $256.00K 10-K · filed 2021-11-24 |
| 2020-09-30 | $618.00K 10-K · filed 2020-11-25 |
| 2020-06-30 | $742.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $855.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $964.00K 10-Q · filed 2020-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |